Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of CD56 expression in smoldering myeloma patients on early progression.
Notarfranchi L, Segreto R, Vescovini R, Dalla Palma AB, Marchica V, Burroughs-Garcia J, Toscani D, Todaro G, Raimondi V, Iannozzi NT, Bonomini S, Sammarelli G, Craviotto L, Pedrazzoni M, Storti P, Giuliani N. Notarfranchi L, et al. Among authors: raimondi v. Hematol Oncol. 2023 Aug;41(3):587-589. doi: 10.1002/hon.3104. Epub 2022 Dec 1. Hematol Oncol. 2023. PMID: 36441875 No abstract available.
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.
Storti P, Marchica V, Vescovini R, Franceschi V, Russo L, Notarfranchi L, Raimondi V, Toscani D, Burroughs Garcia J, Costa F, Dalla Palma B, Iannozzi NT, Sammarelli G, Donofrio G, Giuliani N. Storti P, et al. Among authors: raimondi v. Oncoimmunology. 2022 Sep 6;11(1):2120275. doi: 10.1080/2162402X.2022.2120275. eCollection 2022. Oncoimmunology. 2022. PMID: 36105747 Free PMC article.
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.
Garcia JB, Storti P, Iannozzi NT, Marchica V, Agnelli L, Toscani D, Franceschi V, Todaro G, Sammarelli G, Notarfranchi L, Scita M, Palma BD, Raimondi V, Lungu O, Pruneri G, Donofrio G, Giuliani N. Garcia JB, et al. Among authors: raimondi v. Haematologica. 2024 Feb 1;109(2):627-631. doi: 10.3324/haematol.2023.283200. Haematologica. 2024. PMID: 37608776 Free PMC article. No abstract available.
CD38 expression by plasma cells in extramedullary multiple myeloma.
Notarfranchi L, Accardi F, Mancini C, Martella E, Bonomini S, Segreto R, Vescovini R, Palma ABD, Sammarelli G, Todaro G, Storti P, Burroughs-Garcia J, Iannozzi NT, Raimondi V, Lungu O, Ricci S, Craviotto L, Giuliani N. Notarfranchi L, et al. Among authors: raimondi v. Haematologica. 2024 Apr 1;109(4):1297-1300. doi: 10.3324/haematol.2023.284169. Haematologica. 2024. PMID: 37941401 Free PMC article. No abstract available.
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus.
Silic-Benussi M, Sharova E, Corradin A, Urso L, Raimondi V, Cavallari I, Buldini B, Francescato S, Minuzzo SA, D'Agostino DM, Ciminale V. Silic-Benussi M, et al. Among authors: raimondi v. Antioxidants (Basel). 2023 Mar 3;12(3):625. doi: 10.3390/antiox12030625. Antioxidants (Basel). 2023. PMID: 36978873 Free PMC article.
MiR-150 in HTLV-1 infection and T-cell transformation.
D'Agostino DM, Raimondi V, Silic-Benussi M, Ciminale V. D'Agostino DM, et al. Among authors: raimondi v. Front Immunol. 2022 Aug 16;13:974088. doi: 10.3389/fimmu.2022.974088. eCollection 2022. Front Immunol. 2022. PMID: 36072598 Free PMC article. Review.
40 results